Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00662532 · ClinicalTrials.gov registry record · Phase 3

Antibiotic Study for Dental Implants

A Phase 3 study, sponsored by OraPharma.

Completed
Registry status
Phase 3
Development phase
44
Enrollment target

NCT00662532 is a Phase 3 study that has completed, run by OraPharma. The registered enrollment target is 44 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00662532, a Phase 3 study, has completed, sponsored by OraPharma.

COMPLETED
Registry status
Phase 3
Development phase
44 participants
Enrollment target

Study Summary

This study is for people at least 21 years old who have signs of problems, like swollen gums and shrinking bones, by dental implants.

Interventions

  • DRUG Minocycline HCl

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2008-04
Est. Completion 2009-04
Phase Phase 3

Sponsor

OraPharma

5 total trials

What the Registry Record Tells You About NCT00662532

The ClinicalTrials.gov registry entry for NCT00662532 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OraPharma, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Minocycline HCl is the first listed.

NCT00662532 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00662532 about?

NCT00662532 is a clinical study titled "Antibiotic Study for Dental Implants". This study is for people at least 21 years old who have signs of problems, like swollen gums and shrinking bones, by dental implants.

What is the current status of trial NCT00662532?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 44 participants. The study started on 2008-04. Estimated completion is 2009-04.

What interventions are being tested in trial NCT00662532?

The interventions under investigation include: Minocycline HCl (DRUG).

Who is sponsoring clinical trial NCT00662532?

This trial is sponsored by OraPharma, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.